(R)-3-(4-(5-브로모-2-클로로벤질)페녹시)테트라히드로푸란

(R)-3-(4-(5-브로모-2-클로로벤질)페녹시)테트라히드로푸란
(R)-3-(4-(5-브로모-2-클로로벤질)페녹시)테트라히드로푸란 구조식 이미지
카스 번호:
915095-90-8
한글명:
(R)-3-(4-(5-브로모-2-클로로벤질)페녹시)테트라히드로푸란
동의어(한글):
(R)-3-(4-(5-브로모-2-클로로벤질)페녹시)테트라히드로푸란
상품명:
(R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran
동의어(영문):
Empagliflozin-22;EPG-13A enantiomer;Jardiance Impurity F;Empagliflozin Impurity 73;Empagliflozin Impurity 124;(R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran;Empagliflozin Bromo Impurity / Empagliflozin Impurity 23;(3R)-3-[4-(5-Bromo-2-chlorobenzyl)phenoxy]tetrahydrofuran;(3R)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane;R-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan
CBNumber:
CB32682492
분자식:
C17H16BrClO2
포뮬러 무게:
367.66
MOL 파일:
915095-90-8.mol

(R)-3-(4-(5-브로모-2-클로로벤질)페녹시)테트라히드로푸란 속성

끓는 점
459.1±45.0 °C(Predicted)
밀도
1.431±0.06 g/cm3(Predicted)

안전

(R)-3-(4-(5-브로모-2-클로로벤질)페녹시)테트라히드로푸란 C화학적 특성, 용도, 생산

(R)-3-(4-(5-브로모-2-클로로벤질)페녹시)테트라히드로푸란 준비 용품 및 원자재

원자재

준비 용품


(R)-3-(4-(5-브로모-2-클로로벤질)페녹시)테트라히드로푸란 공급 업체

글로벌( 49)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14332 58
Hangzhou Huarong Pharm Co., Ltd.
571-86758373 +8613588754946
sales@huarongpharm.com CHINA 3148 58
sgtlifesciences pvt ltd
+8617013299288
dj@sgtlifesciences.com China 12373 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11922 58
HANGZHOU LEAP CHEM CO., LTD.
+86-571-87711850
market18@leapchem.com China 43339 58
Moxin Chemicals
+86-17320513646 +8617320513646
anna@molcoo.com China 10000 58
Shanghai Payne Pharmaceutical Technology Co.Ltd
021-58123769 18678586262
info@paynepharm.com China 1354 58
QUALITY CONTROL SOLUTIONS LTD.
+86-0755-66853366 +86-13670046396
export03@qcsrm.com China 24342 58
Adamas Reagent, Ltd. 400-6009262 16621234537
chenyj@titansci.com China 14101 59
Jiangsu Vcare PharmaTech Co., Ltd. 025-58741518 13327700685
sales@vcarepharmatech.com China 308 61

Copyright 2019 © ChemicalBook. All rights reserved